Delivery Order SPE2DB20D3103-SPE2DB25FM2S8

Award Date 1/9/25
Potential Completion Date 1/10/25
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRINTELLIX 20 MG TABLET 30S, a specialty medication. The contract has a firm fixed price of $1,341.21 and a completion date of December 9, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
The U.S. Defense Logistics Agency (DLA) awarded a $1,746.21 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of 4564604011 TRINTELLIX 10 MG TABLET 30S, a prescription pharmaceutical product, with a performance period ending on May 15, 2024. Amerisourcebergen Drug Corp holds a single-award Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of TRINTELLIX 20 MG TABLET 30S, a prescription medication. The total ceiling value of the contract is $2,390.23, and it has a period of performance through July 8, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $8,856.00 firm fixed price delivery order contract to provide TRINTELLIX 10 MG TABLET 30S. This delivery order contract has a completion date of February 21, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and is not subject to any set-aside designations. The company holds an indefinite delivery contract (IDC) valued up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,001.67 firm-fixed-price delivery order is for the supply of TRINTELLIX 10 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of May 9, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order (SPE2DB22D1202|SPE2DB24FUWV1) worth $1,510.80 for the supply of TRINTELLIX 10 MG TABLETs. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the for-profit organization AmerisourceBergen Corporation. The contract is for the delivery of 4,563,817,917 units of TRINTELLIX 10 MG TABLET 30S, a pharmaceutical product, with a potential value of $3,409.92 and a completion date of March 1, 2024. No set-aside designation was used for this contract. AmerisourceBergen Drug Corp holds an Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The $1,738.36 firm fixed price contract is for the supply of 4565535647 - TRINTELLIX 20 MG TABLET 30S, a prescription medication. The award has an ultimate completion date of August 22, 2024 and was issued on August 21, 2024. The contract is not designated as a set-aside. AmerisourceBergen is a major pharmaceutical distributor that...
This federal contract award, valued at $3,414.22, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of TRINTELLIX 20 MG TABLET 30S, a prescription medication, with a period of performance ending on July 8, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical, which...
This federal contract award, valued at $3,825.39, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order for the supply of TRINTELLIX 20 MG TABLET 30S, a prescription medication, to support federal healthcare programs. The contract is not designated as a set-aside and has an ultimate completion date of December 5, 2024. AmerisourceBergen holds a significant Indefinite...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FM2S8
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,219.94, is for the delivery of TRINTELLIX 5 MG TABLET 30S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of January 10, 2025.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. Additionally, AmerisourceBergen maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 4/10/25, 11:26 AM